Future of maraviroc and other CCR5 antagonists

Author： Overton E Turner Powderly William G

ISSN： 1746-0794

Source： Future Virology, Vol.1, Iss.5, 2006-09, pp. : 605-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of HIV infection with the CCR5 antagonist maraviroc

By Kromdijk Wiete Huitema Alwin DR Mulder Jan Willem

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1215-1223

Informa Healthcare

Access to resources Recommend Favorite

Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1504-1514

Bentham Science Publishers

Access to resources Recommend Favorite

CCR5 antagonists for the treatment of HIV

By Schmitz Jens

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 277-282

Govi-Verlag

Access to resources Recommend Favorite

Small Molecule Antagonists of the Chemokine Receptor CCR5

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-09 ,pp. : 1299-1338

Bentham Science Publishers

Access to resources Recommend Favorite

The CCR5 receptor antagonist maraviroc reduces viral load in patients with HIV-1 infection

Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite